Repligen Corporation (RGEN) Revenue-to-Profit Sankey Flow & SEC XBRL Financials
Repligen Corporation (RGEN) receives a Roarable Rating of D (Sell) and flashes a Red SELL / AVOID warning (65/100 RQD Confidence). Our SEC filing scanner spotted paper earnings outpacing real operating cash flow (+253.1% (NI vs OCF)) while unpaid customer invoices grew—a classic sign to step aside until cash flow catches up.
How RGEN Turns Every Dollar of Sales Into Real Bottom-Line Profit
Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory
| Fiscal Year | Revenue | Gross Margin | Op Margin | Net Profit | Free Cash Flow | ROIC % |
|---|---|---|---|---|---|---|
| FY 2025 | $4.00B | 0% | 1.4% | $48.9M | $93.9M | 2.3% |
| FY 2024 | $4.00B | 0% | -0.9% | -$25.5M | $149.7M | -1.7% |
| FY 2023 | $4.00B | 0% | 1.2% | $35.6M | $113.9M | 1.1% |
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring RGEN)
- ✓Live walkthrough of RGEN's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
RGEN Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. -3.3% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on RGEN today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for RGEN. Explore sector supply chains on /butterfly.
RGEN Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDHow profitable is Repligen Corporation (RGEN)?
In FY 2025 (10-K), RGEN converted $4.0B of revenue into a 0% gross margin, 0% operating margin, and $93.9M in free cash flow (2.3% FCF margin).